GZA Ziekenhuizen Campus Sint-Augustinus

Wilrijk 2610

0 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumors, Breast Cancer, Colorectal Cancer, Gastric Cancer, HER2 Amplification, HER2 Positive Solid Tumors, HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HR+/HER2- Breast Cancer, Melanoma, Non Small Cell Lung Cancer, Ovarian Cancer

Studies at this site

• Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma — Running, not enrolling
• ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer — Running, not enrolling
• A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12) — Stopped early
• MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors — Completed
• Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer — Completed
• A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors — Completed
• Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer — Completed
• Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor) — Completed
• Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer — Completed